Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination

被引：25
作者：
Parker, Wendy T. [1 ,2 ]
Phillis, Stuart R. [1 ]
Yeung, David T. O. [1 ,3 ,4 ]
Hughes, Timothy P. [3 ,4 ,5 ]
Scott, Hamish S. [1 ,2 ,4 ,6 ]
Branford, Susan [1 ,2 ,4 ,6 ]
机构：
[1] SA Pathol, Ctr Canc Biol, Dept Genet & Mol Pathol, Adelaide, SA 5000, Australia
[2] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
[3] SA Pathol, Ctr Canc Biol, Dept Hematol, Adelaide, SA 5000, Australia
[4] Univ Adelaide, Sch Med, Adelaide, SA, Australia
[5] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia
[6] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia
来源：
BLOOD | 2014年 / 124卷 / 01期
关键词：
BCR-ABL; INHIBITOR; RESISTANCE; THERAPY;
D O I：
10.1182/blood-2014-05-573485
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：153 / 155
页数：3
相关论文
共 10 条
  • [1] Recombinant DNA sequences generated by PCR amplification
    Bradley, RD
    Hillis, DM
    [J]. MOLECULAR BIOLOGY AND EVOLUTION, 1997, 14 (05) : 592 - 593
  • [2] Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy
    Gibbons, Don L.
    Pricl, Sabrina
    Posocco, Paola
    Laurini, Erik
    Fermeglia, Maurizio
    Sun, Hanshi
    Talpaz, Moshe
    Donato, Nicholas
    Quintas-Cardama, Alfonso
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (09) : 3550 - 3555
  • [3] Bias and artifacts in multitemplate polymerase chain reactions (PCR)
    Kanagawa, T
    [J]. JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2003, 96 (04) : 317 - 323
  • [4] Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing
    Kastner, R.
    Zopf, A.
    Preuner, S.
    Proell, J.
    Niklas, N.
    Foskett, P.
    Valent, P.
    Lion, T.
    Gabriel, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (04) : 793 - 800
  • [5] BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships
    Khorashad, Jamshid S.
    Kelley, Todd W.
    Szankasi, Philippe
    Mason, Clinton C.
    Soverini, Simona
    Adrian, Lauren T.
    Eide, Christopher A.
    Zabriskie, Matthew S.
    Lange, Thoralf
    Estrada, Johanna C.
    Pomicter, Anthony D.
    Eiring, Anna M.
    Kraft, Ira L.
    Anderson, David J.
    Gu, Zhimin
    Alikian, Mary
    Reid, Alistair G.
    Foroni, Letizia
    Marin, David
    Druker, Brian J.
    O'Hare, Thomas
    Deininger, Michael W.
    [J]. BLOOD, 2013, 121 (03) : 489 - 498
  • [6] DNA RECOMBINATION DURING PCR
    MEYERHANS, A
    VARTANIAN, JP
    WAINHOBSON, S
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (07) : 1687 - 1691
  • [7] AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
    O'Hare, Thomas
    Shakespeare, William C.
    Zhu, Xiaotian
    Eide, Christopher A.
    Rivera, Victor M.
    Wang, Frank
    Adrian, Lauren T.
    Zhou, Tianjun
    Huang, Wei-Sheng
    Xu, Qihong
    Metcalf, Chester A., III
    Tyner, Jeffrey W.
    Loriaux, Marc M.
    Corbin, Amie S.
    Wardwell, Scott
    Ning, Yaoyu
    Keats, Jeffrey A.
    Wang, Yihan
    Sundaramoorthi, Raji
    Thomas, Mathew
    Zhou, Dong
    Snodgrass, Joseph
    Commodore, Lois
    Sawyer, Tomi K.
    Dalgarno, David C.
    Deininger, Michael W. N.
    Druker, Brian J.
    Clackson, Tim
    [J]. CANCER CELL, 2009, 16 (05) : 401 - 412
  • [8] Sensitive Detection of BCR-ABL1 Mutations in Patients With Chronic Myeloid Leukemia After Imatinib Resistance Is Predictive of Outcome During Subsequent Therapy
    Parker, Wendy T.
    Lawrence, Rebecca M.
    Ho, Musei
    Irwin, Darryl L.
    Scott, Hamish S.
    Hughes, Timothy P.
    Branford, Susan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) : 4250 - 4259
  • [9] Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain
    Soverini, Simona
    De Benedittis, Caterina
    Polakova, Katerina Machova
    Brouckova, Adela
    Horner, David
    Iacono, Michele
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Papayannidis, Cristina
    Iacobucci, Ilaria
    Venturi, Claudia
    Bochicchio, Maria Teresa
    Klamova, Hana
    Cattina, Federica
    Russo, Domenico
    Bresciani, Paola
    Binotto, Gianni
    Giannini, Barbara
    Kohlmann, Alexander
    Haferlach, Torsten
    Roller, Andreas
    Rosti, Gianantonio
    Cavo, Michele
    Baccarani, Michele
    Martinelli, Giovanni
    [J]. BLOOD, 2013, 122 (09) : 1634 - 1648
  • [10] Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
    Zhang, Jianming
    Adrian, Francisco J.
    Jahnke, Wolfgang
    Cowan-Jacob, Sandra W.
    Li, Allen G.
    Iacob, Roxana E.
    Sim, Taebo
    Powers, John
    Dierks, Christine
    Sun, Fangxian
    Guo, Gui-Rong
    Ding, Qiang
    Okram, Barun
    Choi, Yongmun
    Wojciechowski, Amy
    Deng, Xianming
    Liu, Guoxun
    Fendrich, Gabriele
    Strauss, Andre
    Vajpai, Navratna
    Grzesiek, Stephan
    Tuntland, Tove
    Liu, Yi
    Bursulaya, Badry
    Azam, Mohammad
    Manley, Paul W.
    Engen, John R.
    Daley, George Q.
    Warmuth, Markus
    Gray, Nathanael S.
    [J]. NATURE, 2010, 463 (7280) : 501 - U116
1